Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota
Soil-transmitted helminths infect 1.5 billion people worldwide. Treatment with anthelminthics is the key intervention but interactions between anthelminthic agents and the gut microbiota have not yet been studied. In this study, the effects of four anthelminthic drugs and combinations (tribendimidin...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-12-01
|
Series: | International Journal for Parasitology: Drugs and Drug Resistance |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211320718300575 |
id |
doaj-782470e97bf44660a0d91f23f0c43115 |
---|---|
record_format |
Article |
spelling |
doaj-782470e97bf44660a0d91f23f0c431152020-11-25T00:34:55ZengElsevierInternational Journal for Parasitology: Drugs and Drug Resistance2211-32072018-12-0183372378Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiotaPierre H.H. Schneeberger0Jean T. Coulibaly1Morgan Gueuning2Wendelin Moser3Bryan Coburn4Jürg E. Frey5Jennifer Keiser6Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland; Corresponding author. Department of Medicine, University Health Network, Toronto, ON, M5G 1L7, Canada.Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland; Unité de Formation et de Recherche Biosciences, Université Felix Houphouët-Boigny, Abidjan, Cote d’Ivoire; Centre Suisse de Recherches Scientifiques en Côte d’Ivoire, Abidjan, Cote d’IvoireAgroscope, Department of Method Development and Analytics, Research Group Molecular Diagnostics, Genomics and Bioinformatics, Wädenswil, SwitzerlandDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, SwitzerlandDepartments of Medicine and Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Canada; Department of Medicine, Division of Infectious Diseases, University Health Network, Toronto, CanadaAgroscope, Department of Method Development and Analytics, Research Group Molecular Diagnostics, Genomics and Bioinformatics, Wädenswil, SwitzerlandDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, SwitzerlandSoil-transmitted helminths infect 1.5 billion people worldwide. Treatment with anthelminthics is the key intervention but interactions between anthelminthic agents and the gut microbiota have not yet been studied. In this study, the effects of four anthelminthic drugs and combinations (tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate) on the gut microbiota were assessed. From each hookworm infected adolescent, one stool sample was collected prior to treatment, 24 h post-treatment and 3 weeks post-treatment, and a total of 144 stool samples were analyzed. The gut bacterial composition was analyzed using 16S rRNA gene sequencing. Tribendimidine given alone or together with oxantel-pamoate, and the combination of albendazole and oxantel pamoate were not associated with any major changes in the taxonomic composition of the gut microbiota in this population, at both the short-term post-treatment (24 h) and long-term post-treatment (3 weeks) periods. A high abundance of the bacterial phylum Bacteroidetes was observed following administration of tribendimidine plus ivermectin 24 h after treatment, due predominantly to difference in abundance of the families Prevotellaceae and Candidatus homeothermaceae. This effect is transient and disappears three weeks after treatment. Higher abundance of Bacteroidetes predicts an increase in metabolic pathways involved in the synthesis of B vitamins. This study highlights a strong relationship between tribendimidine and ivermectin administration and the gut microbiota and additional studies assessing the functional aspects as well as potential health-associated outcomes of these interactions are required. Keywords: Soil-transmitted helminths, Gut microbiota, Anthelminthics, Microbiome-drug interactionhttp://www.sciencedirect.com/science/article/pii/S2211320718300575 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Pierre H.H. Schneeberger Jean T. Coulibaly Morgan Gueuning Wendelin Moser Bryan Coburn Jürg E. Frey Jennifer Keiser |
spellingShingle |
Pierre H.H. Schneeberger Jean T. Coulibaly Morgan Gueuning Wendelin Moser Bryan Coburn Jürg E. Frey Jennifer Keiser Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota International Journal for Parasitology: Drugs and Drug Resistance |
author_facet |
Pierre H.H. Schneeberger Jean T. Coulibaly Morgan Gueuning Wendelin Moser Bryan Coburn Jürg E. Frey Jennifer Keiser |
author_sort |
Pierre H.H. Schneeberger |
title |
Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota |
title_short |
Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota |
title_full |
Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota |
title_fullStr |
Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota |
title_full_unstemmed |
Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota |
title_sort |
off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota |
publisher |
Elsevier |
series |
International Journal for Parasitology: Drugs and Drug Resistance |
issn |
2211-3207 |
publishDate |
2018-12-01 |
description |
Soil-transmitted helminths infect 1.5 billion people worldwide. Treatment with anthelminthics is the key intervention but interactions between anthelminthic agents and the gut microbiota have not yet been studied. In this study, the effects of four anthelminthic drugs and combinations (tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate) on the gut microbiota were assessed. From each hookworm infected adolescent, one stool sample was collected prior to treatment, 24 h post-treatment and 3 weeks post-treatment, and a total of 144 stool samples were analyzed. The gut bacterial composition was analyzed using 16S rRNA gene sequencing. Tribendimidine given alone or together with oxantel-pamoate, and the combination of albendazole and oxantel pamoate were not associated with any major changes in the taxonomic composition of the gut microbiota in this population, at both the short-term post-treatment (24 h) and long-term post-treatment (3 weeks) periods. A high abundance of the bacterial phylum Bacteroidetes was observed following administration of tribendimidine plus ivermectin 24 h after treatment, due predominantly to difference in abundance of the families Prevotellaceae and Candidatus homeothermaceae. This effect is transient and disappears three weeks after treatment. Higher abundance of Bacteroidetes predicts an increase in metabolic pathways involved in the synthesis of B vitamins. This study highlights a strong relationship between tribendimidine and ivermectin administration and the gut microbiota and additional studies assessing the functional aspects as well as potential health-associated outcomes of these interactions are required. Keywords: Soil-transmitted helminths, Gut microbiota, Anthelminthics, Microbiome-drug interaction |
url |
http://www.sciencedirect.com/science/article/pii/S2211320718300575 |
work_keys_str_mv |
AT pierrehhschneeberger offtargeteffectsoftribendimidinetribendimidineplusivermectintribendimidineplusoxantelpamoateandalbendazoleplusoxantelpamoateonthehumangutmicrobiota AT jeantcoulibaly offtargeteffectsoftribendimidinetribendimidineplusivermectintribendimidineplusoxantelpamoateandalbendazoleplusoxantelpamoateonthehumangutmicrobiota AT morgangueuning offtargeteffectsoftribendimidinetribendimidineplusivermectintribendimidineplusoxantelpamoateandalbendazoleplusoxantelpamoateonthehumangutmicrobiota AT wendelinmoser offtargeteffectsoftribendimidinetribendimidineplusivermectintribendimidineplusoxantelpamoateandalbendazoleplusoxantelpamoateonthehumangutmicrobiota AT bryancoburn offtargeteffectsoftribendimidinetribendimidineplusivermectintribendimidineplusoxantelpamoateandalbendazoleplusoxantelpamoateonthehumangutmicrobiota AT jurgefrey offtargeteffectsoftribendimidinetribendimidineplusivermectintribendimidineplusoxantelpamoateandalbendazoleplusoxantelpamoateonthehumangutmicrobiota AT jenniferkeiser offtargeteffectsoftribendimidinetribendimidineplusivermectintribendimidineplusoxantelpamoateandalbendazoleplusoxantelpamoateonthehumangutmicrobiota |
_version_ |
1725311432232271872 |